PHS
MNK

PFM Health Sciences’s MALLINCKRODT PUBLIC LIMITED COMPANY MNK Stock Holding History

PFM Health Sciences’s Portfolio MNK Stock Details MNK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,259,100
Closed -$23.5M – 139
2018
Q2 		$23.5M Buy
+1,259,100
New +$20M 0.37% 84
2018
Q1 		– Sell
-1,638,100
Closed -$37M – 106
2017
Q4 		$37M Buy
+1,638,100
New +$43.9M 0.88% 48
2017
Q1 		– Sell
-501,400
Closed -$25M – 128
2016
Q4 		$25M Buy
+501,400
New +$29.5M 0.7% 51

Other funds holding MNK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return